Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions.

MLA

Koldenhof, J., et al. “Symptoms from Treatment with Sunitinib or Sorafenib: A Multicenter Explorative Cohort Study to Explore the Influence of Patient-Reported Outcomes on Therapy Decisions.” Supportive Care in Cancer, vol. 22, no. 9, Sept. 2014, pp. 2371–80. EBSCOhost, https://doi.org/10.1007/s00520-014-2223-2.

APA

Koldenhof, J., Witteveen, P., Vos, R., Walraven, M., Tillier, C., Verheul, H., & Teunissen, S. (2014). Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions. Supportive Care in Cancer, 22(9), 2371–2380. https://doi.org/10.1007/s00520-014-2223-2

Chicago

Koldenhof, J., P. Witteveen, R. Vos, M. Walraven, C. Tillier, H. Verheul, and S. Teunissen. 2014. “Symptoms from Treatment with Sunitinib or Sorafenib: A Multicenter Explorative Cohort Study to Explore the Influence of Patient-Reported Outcomes on Therapy Decisions.” Supportive Care in Cancer 22 (9): 2371–80. doi:10.1007/s00520-014-2223-2.